4DQSAR
Bluelighter
- Joined
- Feb 3, 2025
- Messages
- 5,436
Yeah - I find myself repeatedly having to point out when a paper asserts properties of a compound, they are mostly in vitro or occassionally in vivo using lab mice and don't even get me into the stains used. I was actually surprised to find a primate model and of the three, that showed the least (useful) activity.
I also find myself having to advocate for www.alltrials.net. That charity has only one goal - to legally require researchers to provide ALL the data collected in medical studies. Most people don't know that they are able to supress negative results.
Why does that matter? Well Blers in the UK may remember the CD28-SuperMAB (Theralizumab) scandal. There were serious errors right through the studies but the end result was that six volunteers were hospitalized on 13 March 2006. At least four of them had multiple organ dysfunction.
The thing is, a previous study had uncovered exactly the same issues i.e. the drug was toxic at a dose 500 times lower than that in animal models. But since no study was published, the mistakes were repeated.
If you think about it, a pharmacutical company actually has good reasons not to publish a negative study. Firtly it suggests to shareholders that maybe a billion pounds was wasted, secondly it undermines the reputations of the researchers and thirdly (and possibly most importantly), a pharmacutical company benefits from a competitor wasting a billion pounds.
So if you do one thing today, please, please, please sign the petition and provide what support you can afford. Because next time it could be you or a member of your family who ends up dead.
For context, the previous most infamous example was a large study in children of a novel antibiotic called Trovan (trovafloxin) where even the control group were not provided with the optimal dose of an older antibiotic. I've mentioned this before concerning the fact that Prozac famously was found in studies to be as effective as amitryptaline... yeah, when the lowest dose of amitryptaline was compared with the highest prescribable dose as Prozac!
I also find myself having to advocate for www.alltrials.net. That charity has only one goal - to legally require researchers to provide ALL the data collected in medical studies. Most people don't know that they are able to supress negative results.
Why does that matter? Well Blers in the UK may remember the CD28-SuperMAB (Theralizumab) scandal. There were serious errors right through the studies but the end result was that six volunteers were hospitalized on 13 March 2006. At least four of them had multiple organ dysfunction.
The thing is, a previous study had uncovered exactly the same issues i.e. the drug was toxic at a dose 500 times lower than that in animal models. But since no study was published, the mistakes were repeated.
If you think about it, a pharmacutical company actually has good reasons not to publish a negative study. Firtly it suggests to shareholders that maybe a billion pounds was wasted, secondly it undermines the reputations of the researchers and thirdly (and possibly most importantly), a pharmacutical company benefits from a competitor wasting a billion pounds.
So if you do one thing today, please, please, please sign the petition and provide what support you can afford. Because next time it could be you or a member of your family who ends up dead.
For context, the previous most infamous example was a large study in children of a novel antibiotic called Trovan (trovafloxin) where even the control group were not provided with the optimal dose of an older antibiotic. I've mentioned this before concerning the fact that Prozac famously was found in studies to be as effective as amitryptaline... yeah, when the lowest dose of amitryptaline was compared with the highest prescribable dose as Prozac!
